Biotech is gathering pace: AI systems are simulating novel materials, new genomic technologies are enabling precision bioengineering, and automation is executing production on a massive scale. Softbank Vision Fund Senior Managing Partner, Deep Nishar tells Azeem Azhar why biotech is the next trillion-dollar market, and what breakthroughs to expect.
In this episode they also discuss:

Why emerging biotech and AI, together, would help control and stop coronavirus-like outbreaks in the future.
What new materials and medicines are coming out of the “virtuous cycle” of research and funding that is now taking off.
What the rest of the world should learn from China’s vigorous development of AI technologies.

Further reading:

“As Zymergen Buys EnEvolv, Biological Manufacturing Is Ready To Transform How Industry Makes Everything From Airplanes To Air Jordans” (Forbes, 2020)
“AI just found a new type of antibiotics” (Vox, 2020)

@deepnishar
@azeem
@exponentialview
Exponential View newsletter Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ver todos los episodios